Cav1 |
Caveolin-1 |
Cav2 |
Caveolin-2 |
Cav3 |
Caveolin-3 |
DGC |
Dystrophin glycoprotein complex |
DMD |
Duchene muscular dystrophy |
CSD |
Caveolin scaffolding domain |
PtdIn(4,5)P2 |
Phosphatidylinositol (4,5)-bisphosphate |
ERK1/2 |
Extracellular signal-regulated kinase 1 and 2 |
EGFR |
Epidermal growth factor receptors |
Grb2 |
Growth factor receptor-bound protein 2 |
MAPK |
Mitogen-activated protein kinases |
Atg12 |
Autophagy related 12 |
SV40 |
Simian virus 40 |
NOS |
Nitric oxide synthases |
DYSF |
Dysferlin |
LGMD2B |
Limb-girdle muscular dystrophy type 2B |
DM |
Distal Myopathy |
MM |
Miyoshi myopathy |
PDGF |
Platelet-derived growth factor |
NOS |
Nitric oxide synthases |
DHPRs |
Dihydropyridine receptors |
LQT9 |
Long QT Syndrome 9 |
RYRs |
Ryanodine receptors |
IRS1 |
Insulin receptor substrate 1 |
PFK-M |
Phosphofructokinase-M |
GLUT4 |
Glucose transporter type 4 |
βAR |
Beta-adrenergic receptors |
LRP1 |
Lipoprotein receptor-related protein 1 |
NMJs |
Neuromuscular junctions |
AChRs |
Acetylcholine receptors |
MuSK |
Muscle-specific kinase |
RMD |
Rippling muscle disease |
LGMD |
Limb-girdle muscular dystrophy |
RMD-2 |
Rippling Muscle Disease-2 |
CK |
Creatine kinase |